-
Johnson & Johnson, Zimmer Biomet & DJO: 3 medtech spinoffs in the making
Three new publicly traded device companies are expected to enter the market in the next one to two years, according to announcements from Zimmer Biomet, Johnson & Johnson and Colfax Corp.: -
Johnson & Johnson to split into 2 companies
Johnson & Johnson is dividing into two separate companies; one will focus on its medical devices and drugs, and the other will focus on consumer health products. -
The 6 most high-profile device company acquisitions in 2021
From Johnson & Johnson's latest robotics acquisition to NuVasive's acquisition of an emerging spine technology, here are six medtech deals that caught the eye of readers in 2021. -
Zimmer Biomet, Conformis & more: 8 device company leadership moves in 60 days
From the CFO of Zimmer Biomet's spine and dental spinoff to MicroPort Orthopedics' medical director, here are eight leadership moves since Sept. 12: -
Medtronic exec recognized by National Spine Health Foundation
Linnea Burman, vice president and general manager of Medtronic's enabling technology business, was recognized as Innovator of the Year by the National Spine Health Foundation. -
Medtronic's climate goal, Q3 financial reports & more: 7 device company notes
From third-quarter financial reports to Johnson & Johnson's latest orthopedic acquisition, here are seven key updates from spine and orthopedic device companies in the last week: -
Former Zimmer Biomet CEO joins Think Surgical
David Dvorak, who previously led Zimmer Biomet, was named executive chair of the board of directors at medical device company Think Surgical, according to a Nov. 10 news release. -
NuVasive's net sales dip 8.3%, cervical spine segment grows in US: 5 Q3 notes
NuVasive's net sales were affected in part by challenges with the COVID-19 pandemic and elective surgery halt, according to third-quarter financial results posted Nov. 9. -
Arthrex to pay $16M to settle kickback allegations
Devicemaker Arthrex agreed to pay $16 million to resolve kickback allegations involving a Colorado orthopedic surgeon, the U.S. Justice Department said Nov. 8. -
How Alphatec, Globus Medical and SeaSpine performed in Q3
Alphatec, Globus Medical and SeaSpine posted their third-quarter financial reports, and all of them saw increased revenues year over year. -
Spine, orthopedic implant company closes $3.35M in investment
Happe Spine, a company developing spine and orthopedic implants, closed $3.35 million in series A capital. -
Spinal Elements' 3D-printed interbody system debuts in Ohio and Hawaii
The first clinical cases with Spinal Elements' Lucent 3D-printed lumbar interbody system were completed at Hawaii Pacific Health in Honolulu and Youngstown Orthopedics Associates in Canfield, Ohio. -
Former Johnson & Johnson exec joins orthopedic device company
Conformis named James Paiva as its vice president of U.S. marketing, the company said Nov. 8. -
Medtronic pledges to reach carbon neutrality by 2030
Medtronic plans to achieve net zero carbon emissions by fiscal year 2045, the company announced Nov. 8. -
Johnson & Johnson, Globus Medical ink acquisitions for robotic strategy
A robotics company and the developer of a minimally invasive surgical drill are two of the latest acquisitions in the orthopedic medtech industry: -
New AR spine system nabs U.S. patent, earns award
Bedford, Mass.-based OnPoint Surgical received an award for an augmented reality spine surgery patent that was granted in June, the company said Nov. 8. -
Globus Medical sets Excelsius 3D launch for 2021, acquires surgical drill company: 5 Q3 notes
Globus Medical saw an uptick in revenue year over year in the third quarter, and CEO Dave Demski said in an earnings call that the Excelsius 3D imaging system is expected to launch before the end of the year. -
Alphatec Q3 revenue jumps 53%: 5 notes
Alphatec grew its surgeon user base by 20 percent year over year in the third quarter of 2021, according to financial results posted Nov. 4. -
How Zimmer Biomet, Stryker, Smith+Nephew compare in Q3
Zimmer Biomet, Stryker and Smith+Nephew all recently reported their third quarter results. While Smith+Nephew and Zimmer Biomet saw dips in orthopedic performance, Stryker saw revenue gains. -
Spinal arthroplasty system shows positive outcomes after a year: study
A study of Premia Spine's Tops spinal arthroplasty system found positive patient outcomes at the six-week and 12-month marks.
Page 50 of 190